322 related articles for article (PubMed ID: 6679504)
1. Effect of pyridoxine alpha-ketoglutarate (PAK) on ammonia and pyruvic and lactic acid blood levels in patients with cirrhosis.
Salerno F; Abbiati R; Fici F
Int J Clin Pharmacol Res; 1983; 3(1):21-5. PubMed ID: 6679504
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hyperlactacidemia in cirrhotic patients with pyridoxine-alpha-ketoglutarate (PAK).
Belvisi A; Matergi M; Fici F
Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):142-6. PubMed ID: 7068288
[TBL] [Abstract][Full Text] [Related]
3. Effect of pyridoxine-2-oxoglutarate administration in patients with advanced cirrhosis: control of ammonia pyruvate and lactate high plasma concentrations.
Salerno F; Lorenzini MC; Conti M; Abbiati R; Fici F
Adv Exp Med Biol; 1982; 153():479-85. PubMed ID: 6762055
[No Abstract] [Full Text] [Related]
4. The effect of pyridoxine-alpha-ketoglutarate (PAK) on exercise-induced increase of blood lactate in patients with type I diabetes.
Dall'Aglio E; Zavaroni I; Alpi O; Coscelli C; Butturini U
Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):147-50. PubMed ID: 7068289
[TBL] [Abstract][Full Text] [Related]
5. Effects of pyridoxine alpha-ketoglutarate on blood glucose and lactate in type I and II diabetics.
Passariello N; Fici F; Giugliano D; Ceriello A; Dello Russo P; Sgambato S
Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):252-6. PubMed ID: 6862730
[No Abstract] [Full Text] [Related]
6. Metabolic effects of pyridoxine alpha-ketoglutarate in ophthalmoplegia plus.
Scarlato G; Pellegrini G; Moggio M; Ferini Strambi L
Acta Neurol (Napoli); 1982 Apr; 4(2):92-7. PubMed ID: 7113779
[No Abstract] [Full Text] [Related]
7. [Glucose, lactic acid and pyruvic acid levels of the blood and cerebrospinal fluid in patients with diabetes mellitus and cerebral infarction].
Kawiak W; Stelmasiak Z; Nowicki J; Hasiec T; Gieracz-Nazar A; Wróblewski L
Wiad Lek; 1987 Jul; 40(14):968-74. PubMed ID: 3433766
[No Abstract] [Full Text] [Related]
8. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
[TBL] [Abstract][Full Text] [Related]
9. The effects of glucose on plasma amino acids and pyruvate during upper abdominal surgery.
Obata K; Ogata M; Matsumoto T; Takenaka I; Sata T; Shigematsu A
Anesth Analg; 1993 Feb; 76(2):357-61. PubMed ID: 8424516
[TBL] [Abstract][Full Text] [Related]
10. [Observation of the lactic acid and pyruvic acid levels in blood in liver cirrhosis (author's transl)].
Vykouril J; Kuba M
Cesk Gastroenterol Vyz; 1975 Jan; 29(1):13-7. PubMed ID: 1111978
[No Abstract] [Full Text] [Related]
11. [Lactic and pyruvic acids in the blood in hepatic insufficiency and in hepatic coma].
Gioannini P; Boggiano CA; Scalise G; Nako D
Arch Ital Mal Appar Dig; 1966; 33(6):503-21. PubMed ID: 5997753
[No Abstract] [Full Text] [Related]
12. [Lactic and pyruvic acids in liver cirrhosis before and after the oral administration of glucose. Influence of thioctic acid on such acids].
ORREGO H; WALSHE JM; BRAVO M
Rev Med Chil; 1959 Dec; 87():962-9. PubMed ID: 14429130
[No Abstract] [Full Text] [Related]
13. [Sugar, lactic and pyruvic acid concentration in blood flowing to and from the lungs in various forms of experimental pathology].
Izabolinskaia RM; Grigor'eva KN
Biull Eksp Biol Med; 1967 Jun; 63(6):24-6. PubMed ID: 5622604
[No Abstract] [Full Text] [Related]
14. Treatment of pyruvic and lactic acidaemia in ophthalmoplegia plus.
Scarlato G; Moggio M; Fici F; Cerri C
Adv Exp Med Biol; 1982; 153():487-500. PubMed ID: 6762056
[No Abstract] [Full Text] [Related]
15. Correlations between zinc, amino acids and ammonia in liver cirrhosis.
Grüngreiff K; Presser HJ; Franke D; Lössner B; Abicht K; Kleine FD
Z Gastroenterol; 1989 Dec; 27(12):731-5. PubMed ID: 2626852
[TBL] [Abstract][Full Text] [Related]
16. Disturbances of metabolic homeostasis is liver disease.
Alberti KG; Johnston DG; Piniewska-Hulas M; Whittaker J
Acta Med Port; 1981; (Suppl 2):35-47. PubMed ID: 7015794
[No Abstract] [Full Text] [Related]
17. Early and late changes in fasting and absorptive plasma amino acids and ammonia after distal splenorenal shunt in cirrhosis.
Trevisani F; Bernardi M; Arienti V; Scrivano P; Mazziotti A; Cavallari A; Patrono D; Piazzi S; Gozzetti G; Gasbarrini G
Hepatology; 1994 Feb; 19(2):329-38. PubMed ID: 8294090
[TBL] [Abstract][Full Text] [Related]
18. [Plasma amino acids in patients with liver cirrhosis treated with lactulose].
Giardina MG; Matarazzo M; Prantera T; Verre C; De Marco F
Boll Soc Ital Biol Sper; 1984 Dec; 60(12):2309-16. PubMed ID: 6529509
[TBL] [Abstract][Full Text] [Related]
19. [Lactic and pyruvic acid levels and lactate dehydrogenase activity in the blood in stroke].
Ishchenko MM; Dorogiĭ AN; Shkrobot SI
Vrach Delo; 1984 Jan; (1):86-9. PubMed ID: 6702178
[No Abstract] [Full Text] [Related]
20. Effects of somatostatin on plasma ammonia and amino acid profile during fasting and after protein feeding in cirrhotic patients.
Trevisani F; Bernardi M; De Palma R; Servadei D; Piazzi S; Capelli M; Gasbarrini G
Hepatogastroenterology; 1986 Apr; 33(2):56-60. PubMed ID: 2873093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
